Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
2024ASCO|Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations 2024-06-12 19:31
Growth market USA: Exyte plans to create up to 1,000 new jobs in high-tech facility industry 2024-06-12 19:13
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions 2024-06-12 08:00
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-06-12 02:15
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) 2024-06-11 20:30
Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient 2024-06-11 20:00
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024 2024-06-11 18:00
Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference 2024-06-11 18:00
Chengdu's influence being felt across the world 2024-06-11 16:44
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility 2024-06-11 15:57
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337) 2024-06-11 11:33
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE 2024-06-11 11:25
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024 2024-06-11 08:10
Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting 2024-06-11 08:00
Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond 2024-06-11 08:00
Smartee Successfully Hosts GS Mandibular Repositioning Conference in Spain 2024-06-10 21:19
Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024 2024-06-10 21:09
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024 2024-06-10 20:00
1 55 56 57 58 59 962